Stromal Keratitis After Varicella in Children.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 3 3 2020
medline: 26 3 2021
entrez: 3 3 2020
Statut: ppublish

Résumé

We describe here a case series of patients with stromal keratitis of chronic course, a potential manifestation after chickenpox in children. This is a retrospective review of 8 eyes (7 children) with stromal keratitis after varicella seen in our referral cornea center. All patients received a systemic antiviral treatment with oral acyclovir and topical steroid eye drops. Topical cyclosporine eye drops were associated with steroids in case of steroid dependence or steroid-related side effects. Both antiinflammatory treatments were slowly tapered over time. Median age at diagnosis was 3 years and 4 months. Stromal keratitis was unilateral in 6 children (85.7%) and consisted of superficial nummular keratitis in 4 cases and deep stromal diffuse keratitis in 3 cases. During the median follow-up of 31 months (range, 13-59 months), 6 children had 1 to 6 episodes of relapse. The median duration of topical steroid eye drop was 26 months (range, 2-59 months). Topical cyclosporine eye drops were used with steroids in 3 patients (42.9%). Three patients stopped topical steroids after 2, 5, and 8 months, without recurrence. Four patients were still undergoing treatment after a median of 43 months (range, 26-59 months). All patients regained a best-corrected visual acuity of 20/20 at the end of the follow-up. Stromal keratitis after varicella is an entity with a potential chronic course lasting 3 months or more. Steroid dependence and relapses during tapering are 2 major challenges for the management.

Identifiants

pubmed: 32118671
doi: 10.1097/ICO.0000000000002281
pii: 00003226-202006000-00003
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Ophthalmic Solutions 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

680-684

Références

Réseau Sentinelles, INSERM, UPMC. Available at: http://sentiweb.fr. Accessed January 5, 2019.
Kaufman SC. Anterior segment complications of herpes zoster ophthalmicus. Ophthalmology. 2008;115:S24–S32.
Rousseau A, Bourcier T, Colin J, et al. Herpes zoster ophthalmicus—diagnosis and management. US Ophthalmic Rev. 2013;6:1.
Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115:S3–S12.
Tran KD, Falcone MM, Choi DS, et al. Epidemiology of herpes zoster ophthalmicus: recurrence and chronicity. Ophthalmology. 2016;123:1469–1475.
Jordan DR, Noel LP, Clarke WN. Ocular involvement in varicella. Clin Pediatr (Phila). 1984;23:434–436.
Ostler HB, Thygeson P. The ocular manifestations of herpes zoster, varicella, infectious mononucleosis, and cytomegalovirus disease. Surv Ophthalmol. 1976;21:148–159.
Griffin WP, Searle CWA. Ocular manifestations of varicella. Lancet. 1953;262:168–169.
Kachmer ML, Annable WL, DiMarco M. Iritis in children with varicella. J Pediatr Ophthalmol Strabismus. 1990;27:221–222.
Wilhelmus KR, Hamill MB, Jones DB. Varicella disciform stromal keratitis. Am J Ophthalmol. 1991;111:575–580.
Frandsen E. Chickenpox in the cornea. Acta Ophthalmol (Copenh). 1950;28:113–120.
Uchida Y, Kaneko M, Hayashi K. Varicella dendritic keratitis. Am J Ophthalmol. 1980;89:259–262.
Nesburn AB, Borit A, Pentelei-Molnar J, et al. Varicella dendritic keratitis. Invest Ophthalmol. 1974;13:764–770.
Littlewood KJ, Ouwens MJNM, Sauboin C, et al. Cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in France: an economic analysis based on a dynamic transmission model for varicella and herpes zoster. Clin Ther. 2015;37:830–841.e7.
Zhou F. Impact of varicella vaccination on health care utilization. JAMA. 2005;294:797.
Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352:450–458.
Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. JAMA. 2002;287:606–611.
Pinot de Moira A, Nardone A; ESEN2 Group. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2005;10:43–45.
Rentier B, Gershon AA. Consensus: varicella vaccination of healthy children: a challenge for Europe. Pediatr Infect Dis J. 2004;23:379–389.
Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med. 1999;18:3263–3282.

Auteurs

Margot Denier (M)

Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France; and.

Eric Gabison (E)

Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France; and.

Marwan Sahyoun (M)

Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France; and.

Marc Labetoulle (M)

Department of Ophthalmology, Bicêtre Hospital, Paris, France.

Pascal Dureau (P)

Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France; and.

Isabelle Cochereau (I)

Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France; and.

Serge Doan (S)

Department of Ophthalmology, A de Rothschild Foundation Hospital, Paris, France; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH